Sarcopenia, obesity and sarcopenic obesity: effects on liver function and volume in patients scheduled for major liver resection

Journal of Cachexia, Sarcopenia and Muscle

Volumn , Issue , 2015, Pages 155-163

  Lodewick, Toine M ^a,b,c   Roeth, Anjali A J ^a,c   Olde Damink, Steven W M ^b,c,d   Alizai, Patrick H ^a,c   van Dam, Ronald M ^b,c   Gassler, Nikolaus ^a   Schneider, Mark ^a,c   Dello, Simon A W G ^b   Schmeding, Maximilian ^a,c   Dejong, Cornelis H C ^b,c   Neumann, Ulf P ^a,c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Body fat percentage; L3 skeletal muscle index; LiMAx; Liver function; Obesity; Sarcopenia; Volumetry

Indexed keywords

4 ACETANISIDINE; C REACTIVE PROTEIN;

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BILE DUCT CARCINOMA; BILE LEAKAGE; BILOMA; BODY COMPOSITION; BODY FAT; BODY MASS; BODY SURFACE; BREATH ANALYSIS; CLINICAL ASSESSMENT; COLORECTAL LIVER METASTASIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER RESECTION; LIVER SIZE; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; OBESITY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SARCOPENIA; SARCOPENIC OBESITY; SEPSIS; VOLUMETRY;

EID: 84982113680     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1002/jcsm.12018     Document Type: Article

References (37)

1. de Haas RJ, Wicherts DA, Andreani P, Pascal G, Saliba F, Ichai P, et al. Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg 2011; 253:1069–1079.
2. van der Pool AE, Lalmahomed ZS, de Wilt JH, Eggermont AM, Ijzermans JN, Verhoef C. Trends in treatment for synchronous colorectal liver metastases: differences in outcome before and after 2000. J Surg Oncol 2010; 102:413–418.
3. Schreckenbach T, Liese J, Bechstein WO, Moench C. Posthepatectomy liver failure. Dig Surg 2012; 29:79–85.
4. van den Broek MA, Olde Damink SW, Dejong CH, Lang H, Malago M, Jalan R, et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int : Off J Int Assoc Study Liver. 2008; 28:767–780.
5. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006; 94:982–999.
6. Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 2010; 12:139–146.
7. Stockmann M, Lock JF, Riecke B, Heyne K, Martus P, Fricke M, et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 2009; 250:119–125.
8. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54:289–296.
9. Ferrero A, Vigano L, Polastri R, Muratore A, Eminefendic H, Regge D, et al. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg 2007; 31:1643–1651.
10. Peng PD, van Vledder MG, Tsai S, de Jong MC, Makary M, Ng J, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford) 2011; 13:439–446.
11. Dello SA, Lodewick TM, van Dam RM, Reisinger KW, van den Broek MA, von Meyenfeldt MF, et al. Sarcopenia negatively affects preoperative total functional liver volume in patients undergoing liver resection. HPB (Oxford) 2012.
12. Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, Soejima Y, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013; 100:1523–1530.
13. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res : Off J AmerAssoc Cancer Res 2009; 15:6973–6979.
14. Cauchy F, Zalinski S, Dokmak S, Fuks D, Farges O, Castera L, et al. Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. Br J Surg 2013; 100:113–121.
15. Visser M, van Venrooij LM, Vulperhorst L, de Vos R, Wisselink W, van Leeuwen PA, et al. Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery. Nutr, Metab, Cardiovasc Dis : NMCD 2012.
16. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012; 99:550–557.
17. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646–649.
18. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology (Baltimore, Md) 2001; 33:464–470.
19. Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician 2004; 69:299–304.
20. van der Vorst JR, van Dam RM, van Stiphout RS, van den Broek MA, Hollander IH, Kessels AG, et al. Virtual liver resection and volumetric analysis of the future liver remnant using open source image processing software. World J Surg 2010; 34:2426–2433.
21. Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013;31:1539–1547.
22. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987; 317:1098.
23. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9:629–635.
24. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004; 12:1995–2004.
25. Davison KK, Ford ES, Cogswell ME, Dietz WH. Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc 2002; 50:1802–1809.
26. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: a Critical appraisal of the current evidence. Clin Nutr (Edinburgh, Scotland) 2012; 31:583–601.
27. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology (Baltimore, Md) 1996; 24:289–293.
28. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (Baltimore, Md) 2005; 41:1313–1321.
29. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15:460–466.
30. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205–213.
31. Moon HG, Ju YT, Jeong CY, Jung EJ, Lee YJ, Hong SC, et al. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 2008; 15:1918–1922.
32. Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Ishida K, et al. Influence of overweight on patients with gastric cancer after undergoing curative gastrectomy: an analysis of 689 consecutive cases managed by a single center. Arch Surg 2009; 144:351–358; discussion 8.
33. Benns M, Woodall C, Scoggins C, McMasters K, Martin R. The impact of obesity on outcomes following pancreatectomy for malignancy. Ann Surg Oncol 2009; 16:2565–2569.
34. van Roermund JG, van Basten JP, Kiemeney LA, Karthaus HF, Witjes JA. Impact of obesity on surgical outcomes following open radical prostatectomy. Urol Int 2009; 82:256–261.
35. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42:44–52.
36. Kim HK, Park JY, Lee KU, Lee GE, Jeon SH, Kim JH, et al. Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans. Am J Med Sci 2009; 337:98–102.
37. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39:412–423.